Grape seed proanthocyanidins (GSPs) have been shown to have anti-skin carcinogenic effects in in vitro and in vivo models. However, the precise epigenetic molecular mechanisms remain unexplored. This study was designed to investigate whether GSPs reactivate silenced tumor suppressor genes following epigenetic modifications in
skin cancer cells. For this purpose, A431 and SCC13 human
squamous cell carcinoma cell lines were used as in vitro models. The effects of GSPs on DNA methylation, histone modifications and tumor suppressor gene expressions were studied in these cell lines using
enzyme activity assays, western blotting, dot-blot analysis and real-time polymerase chain reaction (RT-PCR). We found that treatment of A431 and SCC13 cells with GSPs decreased the levels of: (i) global DNA methylation, (ii)
5-methylcytosine, (iii)
DNA methyltransferase (DNMT) activity and (iv)
messenger RNA (
mRNA) and
protein levels of DNMT1, DNMT3a and DNMT3b in these cells. Similar effects were noted when these
cancer cells were treated identically with
5-aza-2'-deoxycytidine, an inhibitor of DNA methylation. GSPs decreased
histone deacetylase activity, increased levels of acetylated lysines 9 and 14 on
histone H3 (H3-Lys 9 and 14) and acetylated lysines 5, 12 and 16 on
histone H4, and reduced the levels of methylated H3-Lys 9. Further, GSP treatment resulted in re-expression of the
mRNA and
proteins of silenced tumor suppressor genes, RASSF1A,
p16(INK4a) and Cip1/p21. Together, this study provides a new insight into the epigenetic mechanisms of GSPs and may have significant implications for epigenetic
therapy in the treatment/prevention of
skin cancers in humans.